Carisma Therapeutics, Inc.
Q3 2024 13F Holders
Symbol
CARM
CUSIP
14216R101
Type
Equity
Class
COM
Num filers
39
Total reported value, excl. options
$5.14M
Compare 2024 Q3 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q2
2024 Q1
2023 Q4
2023 Q3
2023 Q2
2023 Q1
Manager
Report Date
Value ($000)
Shares
Option Type